In 1863, the world’s first underground railway opened in London. On its first day, nearly 40,000 thrilled Brits made the short, speedy journey between Paddington and Farringdon. The future of ...

President Donald Trump has gained 14 pounds since his last physical in April 2025 and has been urged to exercise more as part of his annual heath check. The medical report released late Friday on the ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

Novo Nordisk sees a "major opportunity" outside of the U.S. and says that telehealth partners could help grow the global market for weight loss drugs. The battle for dominance over the lucrative ...

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature Medicine shows that most weight loss achieved using the injectable obesity ...

The National Security Agency is said to be using Mythos Preview, Anthropic’s recently announced model that it withheld from public release, Axios reports. The news comes weeks after the NSA’s parent ...

PCWorld reports that Microsoft’s April Windows 11 update KB5083769 is causing severe boot loops and Blue Screen of Death crashes on some PCs. The issue particularly affects HP and Dell computers, ...

We don't really understand AI's inner workings, so we're effectively flying blind. The availability of artificial intelligence for use in warfare is at the center of a legal battle between Anthropic ...

NEW YORK, April 9 (Reuters) - Amazon.com (AMZN.O), opens new tab said on Thursday its pharmacy unit will stock Eli Lilly's (LLY.N), opens new tab new weight-loss pill at kiosks located at some of the ...

Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...